Jessica Yau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jessica Yau has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn Hughes Barry
Department of Epidemiology and Public Health University of Maryland School of Medicine Baltimore Maryland USA
10 shared publications - Arif Hussain
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
9 shared publications - Cheryl L. Holt
Department of Behavioral and Community Health, University of Maryland School of Public Health, College Park, Maryland
9 shared publications - David C. Wheeler
Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA
9 shared publications - Derrick A. Butts
Prostate Health Matters, Washington, District of Columbia. 5
9 shared publications - Eberechukwu Onukwugha
Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, MD
9 shared publications
Latest Publications
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S1: Summary of correlations between neighborhood disadvantage metrics.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S1: Summary of correlations between neighborhood disadvantage metrics.
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Figure S2: Values of the Neighborhood Deprivation Index (NDI) for participants with residential addresses in Baltimore.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Figure S2: Values of the Neighborhood Deprivation Index (NDI) for participants with residential addresses in Baltimore.
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S2: Summary of sensitivity analyses for models by neighborhood metric.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S2: Summary of sensitivity analyses for models by neighborhood metric.
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Figure S1: Values of the Area Deprivation Index (ADI) for participants with residential addresses in Maryland.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Figure S1: Values of the Area Deprivation Index (ADI) for participants with residential addresses in Maryland.
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Figure S3: Values of the Racial Isolation (RI) index for participants with residential addresses in Maryland.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Figure S3: Values of the Racial Isolation (RI) index for participants with residential addresses in Maryland.
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S4: Summary of models by neighborhood metric when only using clinical information to classify prostate tumor aggressiveness.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S4: Summary of models by neighborhood metric when only using clinical information to classify prostate tumor aggressiveness.
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S3: Summary of models of neighborhood disadvantage and the likelihood of aggressive prostate cancer by neighborhood metric, additionally adjusting for primary payer at diagnosis.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Supplementary Table S3: Summary of models of neighborhood disadvantage and the likelihood of aggressive prostate cancer by neighborhood metric, additionally adjusting for primary payer at diagnosis.
- Open Access
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Data from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Background:Studies have identified associations between neighborhood disadvantage (ND), which is more likely to affect African American (AA) individuals, and aggressive prostate cancer. Thus, ND may contribute to prostate cancer disparities. However, it is unknown what ND components drive aggressive disease and whether associations vary by race.Methods:We evaluated associations between aggressive prostate cancer and four ND metrics—Area Deprivation Index (ADI), validated Bayesian Neighborhood Deprivation Index (NDI), racial isolation (RI) index, and historical redlining, and whether these factors interacted with race, among men with prostate cancer treated at the University of Maryland Greenebaum Comprehensive Cancer Center (2004–2021).Results:We included 1,458 men (698 European American and 760 AA). AA men were more likely to experience ND. In adjusted models, the ADI, RI, and redlining were significantly associated with aggressive versus nonaggressive prostate cancer overall [ADI, OR for one SD increase = 1.14, 95% confidence interval (CI), 1.00–1.30; RI, OR = 1.27, CI, 1.07–1.51; redlining, OR = 1.77; CI, 1.23–2.56] and among AA men. The NDI was associated with aggressive prostate cancer among AA men (OR = 1.32, 95% credible interval: 1.13–1.57); percent in poverty received the largest importance weight. The ADI (P heterogeneity = 0.002) and NDI (exceedance probability heterogeneity = 98.1%) significantly interacted with race, such that associations were significantly stronger for AA men.Conclusions:We identified novel significant positive associations for racial segregation and historical redlining with aggressive prostate cancer and significant interactions between ND indices and race.Impact:Findings inform specific ND components that are associated with aggressive prostate cancer and suggest the ND effect is stronger for AA men, which has implications for interventions to reduce disparities.
- 2 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Background:Studies have identified associations between neighborhood disadvantage (ND), which is more likely to affect African American (AA) individuals, and aggressive prostate cancer. Thus, ND may contribute to prostate cancer disparities. However, it is unknown what ND components drive aggressive disease and whether associations vary by race.Methods:We evaluated associations between aggressive prostate cancer and four ND metrics—Area Deprivation Index (ADI), validated Bayesian Neighborhood Deprivation Index (NDI), racial isolation (RI) index, and historical redlining, and whether these factors interacted with race, among men with prostate cancer treated at the University of Maryland Greenebaum Comprehensive Cancer Center (2004–2021).Results:We included 1,458 men (698 European American and 760 AA). AA men were more likely to experience ND. In adjusted models, the ADI, RI, and redlining were significantly associated with aggressive versus nonaggressive prostate cancer overall [ADI, OR for one SD increase = 1.14, 95% confidence interval (CI), 1.00–1.30; RI, OR = 1.27, CI, 1.07–1.51; redlining, OR = 1.77; CI, 1.23–2.56] and among AA men. The NDI was associated with aggressive prostate cancer among AA men (OR = 1.32, 95% credible interval: 1.13–1.57); percent in poverty received the largest importance weight. The ADI (P heterogeneity = 0.002) and NDI (exceedance probability heterogeneity = 98.1%) significantly interacted with race, such that associations were significantly stronger for AA men.Conclusions:We identified novel significant positive associations for racial segregation and historical redlining with aggressive prostate cancer and significant interactions between ND indices and race.Impact:Findings inform specific ND components that are associated with aggressive prostate cancer and suggest the ND effect is stronger for AA men, which has implications for interventions to reduce disparities.
- 9 August 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (10) , 1318-1326
Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Background: Studies have identified associations between neighborhood disadvantage (ND), which is more likely to affect African American (AA) individuals, and aggressive prostate cancer. Thus, ND may contribute to prostate cancer disparities. However, it is unknown what ND components drive aggressive disease and whether associations vary by race. Methods: We evaluated associations between aggressive prostate cancer and four ND metrics—Area Deprivation Index (ADI), validated Bayesian Neighborhood Deprivation Index (NDI), racial isolation (RI) index, and historical redlining, and whether these factors interacted with race, among men with prostate cancer treated at the University of Maryland Greenebaum Comprehensive Cancer Center (2004–2021). Results: We included 1,458 men (698 European American and 760 AA). AA men were more likely to experience ND. In adjusted models, the ADI, RI, and redlining were significantly associated with aggressive versus nonaggressive prostate cancer overall [ADI, OR for one SD increase = 1.14, 95% confidence interval (CI), 1.00–1.30; RI, OR = 1.27, CI, 1.07–1.51; redlining, OR = 1.77; CI, 1.23–2.56] and among AA men. The NDI was associated with aggressive prostate cancer among AA men (OR = 1.32, 95% credible interval: 1.13–1.57); percent in poverty received the largest importance weight. The ADI (P heterogeneity = 0.002) and NDI (exceedance probability heterogeneity = 98.1%) significantly interacted with race, such that associations were significantly stronger for AA men. Conclusions: We identified novel significant positive associations for racial segregation and historical redlining with aggressive prostate cancer and significant interactions between ND indices and race. Impact: Findings inform specific ND components that are associated with aggressive prostate cancer and suggest the ND effect is stronger for AA men, which has implications for interventions to reduce disparities.
- 9 August 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (10) , 1318-1326
Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men
Background: Studies have identified associations between neighborhood disadvantage (ND), which is more likely to affect African American (AA) individuals, and aggressive prostate cancer. Thus, ND may contribute to prostate cancer disparities. However, it is unknown what ND components drive aggressive disease and whether associations vary by race. Methods: We evaluated associations between aggressive prostate cancer and four ND metrics—Area Deprivation Index (ADI), validated Bayesian Neighborhood Deprivation Index (NDI), racial isolation (RI) index, and historical redlining, and whether these factors interacted with race, among men with prostate cancer treated at the University of Maryland Greenebaum Comprehensive Cancer Center (2004–2021). Results: We included 1,458 men (698 European American and 760 AA). AA men were more likely to experience ND. In adjusted models, the ADI, RI, and redlining were significantly associated with aggressive versus nonaggressive prostate cancer overall [ADI, OR for one SD increase = 1.14, 95% confidence interval (CI), 1.00–1.30; RI, OR = 1.27, CI, 1.07–1.51; redlining, OR = 1.77; CI, 1.23–2.56] and among AA men. The NDI was associated with aggressive prostate cancer among AA men (OR = 1.32, 95% credible interval: 1.13–1.57); percent in poverty received the largest importance weight. The ADI (P heterogeneity = 0.002) and NDI (exceedance probability heterogeneity = 98.1%) significantly interacted with race, such that associations were significantly stronger for AA men. Conclusions: We identified novel significant positive associations for racial segregation and historical redlining with aggressive prostate cancer and significant interactions between ND indices and race. Impact: Findings inform specific ND components that are associated with aggressive prostate cancer and suggest the ND effect is stronger for AA men, which has implications for interventions to reduce disparities.
- 4 April 2023
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (7_Suppleme) , 1897
Abstract 1897: RNA expression markers with differential expression by race/ancestry are associated with prostate tumor aggressiveness among African American men
There is growing evidence of molecular differences in prostate tumors by race or ancestry, which may contribute to the disproportionate burden of aggressive prostate cancer for African American men. Here we investigated whether RNA expression of 310 genes or non-coding RNAs that have shown differential expression (p=7 vs. <=6). The Benjamini-Hochberg False Discovery Rate approach was used to adjust for multiple comparisons. Of the 310 genes/non-coding RNAs, 110 were significantly associated with GS (p=7: 4.3, 4.0-4.5; p=9.90E-05; q=0.01) and zinc finger homeobox 3 (ZFHX3; median and IQR for GS<=6: 4.0, 3.7-4.7 and GS>=7: 3.7, 3.5-4.0; p=1.30E-04; q=0.01). Notably, both genes were found to have lower expression in prostate tumor tissue in African American men compared to European American men in previous studies. Therefore, the direction of our findings with GS (lower expression for higher-grade tumors) is consistent with a potential role of these genes in prostate cancer disparities. The genes that had higher expression in higher- vs. lower-grade tumors in our study included several genes that have shown higher expression in tumor tissue from African American men than European American men in previous studies. These included splicing factor 1 (SF1; median and IQR for GS<=6: 3.5, 3.1-5.1 and GS>=7: 4.6, 3.3-7.4; p=5.60E-03; q=0.04), uroplakin 3B-like (UPK3BL; median and IQR for GS<=6: 6.1, 4.9-7.7 and GS>=7: 7.4, 5.5-9.3; p=7.20E-03; q= 0.04), and RNA binding motif protein 6 (RBM6; median and IQR for GS<=6: 9.6, 8.2-10.7 and GS>=7: 10.3, 8.9-12.1; p=0.01; q=0.05). While replication is needed, these findings add to growing evidence that RNA expression differences in prostate tumors by race or ancestry may contribute to prostate tumor aggressiveness and prostate cancer disparities. Citation Format: Jessica Yau, Ebuka Onyenobi, Yuji Zhang, Teklu B. Legesse, Gary Rose, Guangjing Zhu, Allen Burke, Ashley Cellini, Kimberly Clark, Nicholas Ambulos, Jing Yin, Søren M. Bentzen, Arif Hussain, Joanne Dorgan, Lorelei A. Mucci, Kathryn Hughes Barry. RNA expression markers with differential expression by race/ancestry are associated with prostate tumor aggressiveness among African American men [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1897.
- 4 April 2023
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (7_Suppleme) , 1897
Abstract 1897: RNA expression markers with differential expression by race/ancestry are associated with prostate tumor aggressiveness among African American men
There is growing evidence of molecular differences in prostate tumors by race or ancestry, which may contribute to the disproportionate burden of aggressive prostate cancer for African American men. Here we investigated whether RNA expression of 310 genes or non-coding RNAs that have shown differential expression (p=7 vs. <=6). The Benjamini-Hochberg False Discovery Rate approach was used to adjust for multiple comparisons. Of the 310 genes/non-coding RNAs, 110 were significantly associated with GS (p=7: 4.3, 4.0-4.5; p=9.90E-05; q=0.01) and zinc finger homeobox 3 (ZFHX3; median and IQR for GS<=6: 4.0, 3.7-4.7 and GS>=7: 3.7, 3.5-4.0; p=1.30E-04; q=0.01). Notably, both genes were found to have lower expression in prostate tumor tissue in African American men compared to European American men in previous studies. Therefore, the direction of our findings with GS (lower expression for higher-grade tumors) is consistent with a potential role of these genes in prostate cancer disparities. The genes that had higher expression in higher- vs. lower-grade tumors in our study included several genes that have shown higher expression in tumor tissue from African American men than European American men in previous studies. These included splicing factor 1 (SF1; median and IQR for GS<=6: 3.5, 3.1-5.1 and GS>=7: 4.6, 3.3-7.4; p=5.60E-03; q=0.04), uroplakin 3B-like (UPK3BL; median and IQR for GS<=6: 6.1, 4.9-7.7 and GS>=7: 7.4, 5.5-9.3; p=7.20E-03; q= 0.04), and RNA binding motif protein 6 (RBM6; median and IQR for GS<=6: 9.6, 8.2-10.7 and GS>=7: 10.3, 8.9-12.1; p=0.01; q=0.05). While replication is needed, these findings add to growing evidence that RNA expression differences in prostate tumors by race or ancestry may contribute to prostate tumor aggressiveness and prostate cancer disparities. Citation Format: Jessica Yau, Ebuka Onyenobi, Yuji Zhang, Teklu B. Legesse, Gary Rose, Guangjing Zhu, Allen Burke, Ashley Cellini, Kimberly Clark, Nicholas Ambulos, Jing Yin, Søren M. Bentzen, Arif Hussain, Joanne Dorgan, Lorelei A. Mucci, Kathryn Hughes Barry. RNA expression markers with differential expression by race/ancestry are associated with prostate tumor aggressiveness among African American men [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1897.